PT1331001E - Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes - Google Patents

Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes

Info

Publication number
PT1331001E
PT1331001E PT01976327T PT01976327T PT1331001E PT 1331001 E PT1331001 E PT 1331001E PT 01976327 T PT01976327 T PT 01976327T PT 01976327 T PT01976327 T PT 01976327T PT 1331001 E PT1331001 E PT 1331001E
Authority
PT
Portugal
Prior art keywords
paracetamol
dispersible
granulate
order
soluable
Prior art date
Application number
PT01976327T
Other languages
English (en)
Inventor
Luis Carvajal Martin
Juan Carlos Asensio Asensio
Francisco Javier Sevill Tirado
Original Assignee
Belmac S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belmac S A Lab filed Critical Belmac S A Lab
Publication of PT1331001E publication Critical patent/PT1331001E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01976327T 2000-11-03 2001-10-24 Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes PT1331001E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200002653A ES2174734B1 (es) 2000-11-03 2000-11-03 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.

Publications (1)

Publication Number Publication Date
PT1331001E true PT1331001E (pt) 2004-11-30

Family

ID=8495530

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01976327T PT1331001E (pt) 2000-11-03 2001-10-24 Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes

Country Status (9)

Country Link
US (1) US6620433B2 (pt)
EP (1) EP1331001B1 (pt)
JP (1) JP2004512355A (pt)
AT (1) ATE271378T1 (pt)
DE (1) DE60104442T2 (pt)
ES (1) ES2174734B1 (pt)
PL (1) PL355106A1 (pt)
PT (1) PT1331001E (pt)
WO (1) WO2002036101A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6581767B2 (en) * 2001-08-20 2003-06-24 Wen-Chien Cheng Golf bag base
ES2344294T3 (es) * 2003-05-02 2010-08-24 Globopharm Pharmazeutische Produktions- Und Handelsgesellschaft M.B.H. Preparacion farmaceutica solida que contiene sales de levotiroxina y/o liotironina.
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
KR101465647B1 (ko) * 2013-02-25 2014-11-27 김성호 가용성 타블렛형 청즙차의 제조방법
LT3069733T (lt) * 2013-11-13 2022-11-25 National Defense Education And Research Foundation Nauja acetaminofeno junginio sudėtis be šalutinio poveikio kepenims
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893B1 (pt) 1970-06-29 1973-07-13 Bru Jean
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA1209040A (fr) * 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
EP0377906B1 (en) * 1989-01-12 1993-12-15 Bayer Ag Effervescent analgesic antacid composition having reduced sodium content
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
ATE246915T1 (de) * 1998-11-23 2003-08-15 E Pharma Trento Spa Verfahren zur herstellung eines brausegranulats
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions

Also Published As

Publication number Publication date
JP2004512355A (ja) 2004-04-22
ES2174734A1 (es) 2002-11-01
WO2002036101A1 (es) 2002-05-10
ES2174734B1 (es) 2003-10-01
DE60104442T2 (de) 2005-09-15
PL355106A1 (en) 2004-04-05
EP1331001A1 (en) 2003-07-30
US6620433B2 (en) 2003-09-16
ATE271378T1 (de) 2004-08-15
US20020197312A1 (en) 2002-12-26
DE60104442D1 (de) 2004-08-26
EP1331001B1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
YU22794A (sh) Veterinarska kompozicija
DK455286D0 (da) Farmaceutisk middel med langsom frigaering og fremgangsmaade til dets fremstilling
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
NZ332295A (en) Spray-dried hydrolyzed cellulose granulations for pharmaceuticals such as ibuprofen
ATE261300T1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
GB2395662A (en) Emollient skin conditioning cream and method
NO20002133L (no) Oppløsninger og dispersjoner i fast tilstand av svakt vannoppløselige legemidler
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
PT1331001E (pt) Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes
UA5328A1 (uk) Спосіб одержання таблеток
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
IL150528A0 (en) Ibuprofen containing active agent preparation
ATE329582T1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
HRP20020181B1 (hr) Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak
JP3170139B2 (ja) 発泡性錠剤
ATE266404T1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
ID26240A (id) Formulasi obat setengah padat yang mengandung dekstoprofen trometamol
ES2047540T3 (es) Compuesto farmaceutico y procedimiento para su preparacion.
DE60123447D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
RU96110702A (ru) Способ получения анальгезирующего жаропонижающего средства
PL368073A1 (en) Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease
TH43075A (th) สารผสมตามสูตรที่ควบคุมการปลดปล่อยสำหรับการรักษา copd